These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 567375)

  • 1. Histidine-rich protein as a model malaria vaccine.
    Kilejian A
    Science; 1978 Sep; 201(4359):922-4. PubMed ID: 567375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological cross-reactivity of the histidine-rich protein of Plasmodium lophurae and the knob protein of Plasmodium falciparum.
    Kilejian A
    J Parasitol; 1983 Apr; 69(2):257-61. PubMed ID: 6189987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium lophurae: protective immunogenicity of the histidine-rich protein?
    Sherman IW
    Exp Parasitol; 1981 Oct; 52(2):292-5. PubMed ID: 7274373
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmodium iophurae: immunization of Pekin ducklings with different antigen preparations.
    McDonald V; Hannon M; Tanigoshi L; Sherman IW
    Exp Parasitol; 1981 Apr; 51(2):195-203. PubMed ID: 7202632
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.
    Playfair JH; De Souza JB; Cottrell BJ
    Immunology; 1977 Oct; 33(4):507-15. PubMed ID: 336522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a histidine-rich protein from Plasmodium lophurae have a function in merozoite penetration?
    Kilejian A
    J Protozool; 1976 May; 23(2):272-7. PubMed ID: 933084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse mechanisms in malaria: emergence of variant strains of Plasmodium lophurae from serum antigen-immunized ducks.
    Corwin RM; Cox HW; Ludford CG; McNett SL
    J Parasitol; 1970 Jun; 56(3):431-8. PubMed ID: 5421083
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization against erythrocytic forms of malaria parasites.
    Cohen S; Butcher GA; Mitchell GH
    Adv Exp Med Biol; 1977; 93():89-112. PubMed ID: 596300
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of sporozoite vaccines.
    Nussenzweig RS; Nussenzweig V
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):117-28. PubMed ID: 6084251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole parasite vaccination approaches for prevention of malaria infection.
    Butler NS; Vaughan AM; Harty JT; Kappe SH
    Trends Immunol; 2012 May; 33(5):247-54. PubMed ID: 22405559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with purified microgamete antigens prevents transmission of rodent malaria.
    Harte PG; Rogers N; Targett GA
    Nature; 1985 Jul 18-24; 316(6025):258-9. PubMed ID: 4022122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A merozoite vaccine effective against Plasmodium knowlesi malaria.
    Mitchell GH; Butcher GA; Cohen S
    Nature; 1974 Nov; 252(5481):311-3. PubMed ID: 4431452
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
    Scorza T; Grubb K; Smooker P; Rainczuk A; Proll D; Spithill TW
    Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.
    Freeman RR; Trejdosiewicz AJ; Cross GA
    Nature; 1980 Mar; 284(5754):366-8. PubMed ID: 7360274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium lophurae: immunogenicity of a histidine-rich protein.
    Kilejian A
    Exp Parasitol; 1981 Oct; 52(2):291. PubMed ID: 7274372
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.
    Freeman RR; Holder AA
    Clin Exp Immunol; 1983 Dec; 54(3):609-16. PubMed ID: 6652973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of metozoite vaccination against Plasmodium knowlesi malaria.
    Mitchell GH
    Trans R Soc Trop Med Hyg; 1977; 71(4):281-2. PubMed ID: 413214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed allele malaria vaccines: host protection and within-host selection.
    Barclay VC; Chan BH; Anders RF; Read AF
    Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology between a histidine-rich protein from Plasmodium lophurae and a protein associated with the knob-like protrusions on membranes of erythrocytes infected with Plasmodium falciparum.
    Kilejian A
    J Exp Med; 1980 Jun; 151(6):1534-8. PubMed ID: 6991629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.